Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: An important step in the early defense against fungal infections?

References

• Goldman L, Ausiello D. Cecil medicine. Saunders Elsevier, Philadelphia, PA 2008
   Google Scholar
• Robbins CS, Swirski FK. The multiple roles of monocyte subsets in steady state and inflammation. Cell Mol Life Sci. 2010; 67(16)2685–2693
   PubMedGoogle Scholar
• Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat Immunol. 2010; 11(10)889–896
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N, Mitchell RS. Basic pathology8th. Elsevier Saunders, Philadelphia, PA 2007
   Google Scholar
• Semple JW, Italiano JE, Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011; 11(4)264–274
   PubMed Web of Science ®Google Scholar
• Hartwig J. Mechanism of actin rearrangements mediating platelets activation. J Cell Biol 1992; 118: 1421–1442
   PubMed Web of Science ®Google Scholar
• Quinn M, Fitzgerald D, Cox D. Platelet function: Assessment, diagnosis, and treatment. Humana Press, Inc, Totowa, NJ 2005
   Google Scholar
• Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678–689
   PubMed Web of Science ®Google Scholar
• Wagner DD, Frenette PS. The vessel wall and its interactions. Blood 2008; 111: 5271–5281
   PubMed Web of Science ®Google Scholar
• Hammer DA, Apte SM. Simulation of cell rolling and adhesion on surfaces of shear flow: General results and analysis of selectin-mediated neutrophil adhesion. Biophys J 1992; 63: 35–57
   PubMed Web of Science ®Google Scholar
• Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. Platelet functions beyond hemostasis. J Thromb Haemost. 2009; 7(11)1759–1766
   PubMed Web of Science ®Google Scholar
• Zarbock A, Ley K. The role of platelets in acute lung injury. Front Biosci 2009; 14: 150–158
   PubMed Web of Science ®Google Scholar
• Miner JJ, Xia L, Yago T, Kappelmayer J, Liu Z, Klopocki AG, Shao B, McDaniel JM, Setiadi H, Schmidtke DW, et al. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 2008; 112(5)2035–2045
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: Role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995; 74(1)224–227
   PubMed Web of Science ®Google Scholar
• Mantovati A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004; 25(12)677–686
   PubMedGoogle Scholar
• Bruserud O, Halstensen A, Peen E, Solberg CO. Serum levels of adhesion molecules and cytokines in patients with acute leukaemia. Leuk Lymphoma 1996; 23(5–6)423–430
   PubMed Web of Science ®Google Scholar
• Bruserud O, Akselen PE, Bergheim J, Nesthus I. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy-induced leucopenia and bacterial infections. Br J Haematol. 1995; 91(2)394–402
   PubMed Web of Science ®Google Scholar
• Apelseth TO, Hervig T, Wentzel-Larsen T, Petersen K, Reikvam H, Bruserud O. A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. Eur Cytokine Netw 2011; 22(1)52–62
   PubMedGoogle Scholar
• Apelseth TO, Hervig TA, Wentzel-Larsen T, Bruserud O. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion. 2006; 46(5)800–810
   PubMed Web of Science ®Google Scholar
• Olsnes AM, Hatfield KJ, Bruserud O. The chemokine system and its contribution to leukogenesis and treatment responsiveness in patients with acute myeloid leukemia. J BUON 2009; 14 (Suppl 1)S131–S140
   PubMedGoogle Scholar
• Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. IL-1beta processing in host defense: Beyond the inflammasomes. PLoS Pathog. 2010; 26;6(2)e1000661
   Google Scholar
• Gear AR, Camerini D. Platelet chemokines and chemokine receptors: Linking hemostasis, inflammation, and host defense. Microcirculation. 2003; 10(3–4)335–350
   PubMedGoogle Scholar
• Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 2008; 28(11)1920–1927
   PubMed Web of Science ®Google Scholar
• Erlandsson HH, Andersson U. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol. 2004; 34(6)1503–1512
   PubMedGoogle Scholar
• Sasaguri Y, Tanimoto A. Role of macrophage-derived histamine in atherosclerosis chronic participation in the inflammatory response. J Atheroscler Thromb 2004; 11(3)122–130
   PubMedGoogle Scholar
• Cloëz-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: A perspective. J Leukoc Biol 2007; 81(3)599–606
   PubMedGoogle Scholar
• Chamorro A. TP receptor antagonism: A new concept in atherothrombosis and stroke prevention. Cerebrovasc Dis 2009; 27(Suppl 3)20–27
   PubMedGoogle Scholar
• McManus LM, Pinckard RN. PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med. 2000; 11(2)240–258
   PubMedGoogle Scholar
• Bezuidenhout L, Bracher M, Davison G, Zilla P, Davies N. Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis. J Leukoc Biol. 2007; 81(6)1496–1503
   PubMedGoogle Scholar
• Bezuidenhout L, Zilla P, Davies N. Association of Ang-2 with integrin beta 2 controls Ang-2/PDGF-BB-dependent upregulation of human peripheral blood monocyte fibrinolysis. Inflammation. 2009; 32(6)393–401
   PubMedGoogle Scholar
• Tessarz AS, Cerwenka A. The TREM-1/DAP12 pathway. Immunol Lett 2007; 116(2)111–116
   PubMedGoogle Scholar
• Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117(14)3720–3732
   PubMed Web of Science ®Google Scholar
• Suttles J, Stout RD. Macrophage CD40 signaling: A pivotal regulator of disease protection and pathogenesis. Semin Immunol 2009; 21(5)257–264
   PubMedGoogle Scholar
• Pervushina O, Scheuerer B, Reiling N, Behnke L, Schrøder JM, Kasper B, Brandt E, Bulfone-Paus S, Petersen F. Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J Immunol 2004; 173(3)2060–2067
   PubMedGoogle Scholar
• Bertling A, Niemann S, Uekötter A, Fegeler W, Lass-Flörl C, von Eiff C, Kehrel BE. Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols. Thromb Haemost 2010; 104(2)270–278
   PubMed Web of Science ®Google Scholar
• Rotrosen D, Calderone RA, Edwards JE, Jr. Adherence of Candida species to host tissues and plastic surfaces. Rev Infect Dis 1986; 8(1)73–85
   PubMedGoogle Scholar
• Maisch PA, Calderone RA. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun 1980; 27(2)650–656
   PubMedGoogle Scholar
• Robert R, Nail S, Marot-Leblond A, Cottin J, Miegeville M, Quenouillere S, Mahaza C, Senet JM. Adherence of platelets to Candida species in vivo. Infect Immun 2000; 68(2)570–576
   PubMedGoogle Scholar
• Robert R, Mahaza C, Miegeville M, Ponton J, Marot-Leblond A, Senet JM. Binding of resting platelets to Candida albicans germ tubes. Infect Immun 1996; 64(9)3752–3757
   PubMedGoogle Scholar
• Yeaman MR, Sullam PM, Dazin PF, Ghannoum MA, Edwards JE, Jr, Bayer AS. Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob Agents Chemother 1994; 38(7)1460–1465
   PubMedGoogle Scholar
• Yeaman MR, Soldan SS, Ghannoum MA, Edwards JE, Jr, Filler SG, Bayer AS. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun 1996; 64(4)1379–1384
   PubMedGoogle Scholar
• Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, von Eiff C, Lass-Flörl C. Human platelets attenuate Aspergillus species via granule-dependent mechanism. J Infect Dis 2008; 198(8)1243–1246
   PubMed Web of Science ®Google Scholar
• Yoshida M, Roth RI, Grunfeld C, Feingold KR, Levin J. Soluble (1–>3)-beta-D-glucan purified from Candida albicans: Biologic effects and distribution in blood and organs in rabbits. J Lab Clin Med 1996; 128(1)103–114
   PubMedGoogle Scholar
• Kang JY, Lee JO. Structural biology of the Toll-like receptor family. Annu Rev Biochem 2011; 80: 917–941
   PubMedGoogle Scholar
• Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure 2011; 19(4)447–459
   PubMed Web of Science ®Google Scholar
• Cole JE, Georgiou E, Monaco C. The expression and functions of Toll-like receptors in atherosclerosis. Mediators Inflamm 2010; 393946
   PubMedGoogle Scholar
• Cognasse F, Hamzeh-Cognasse H, Garraud O. Platelets “Toll-like receptor” engagement stimulates the release of immunomodulating molecules. Transfus Clin Biol 2008; 15(4)139–147
   PubMedGoogle Scholar
• Garraud O, Cognasse F. Platelet Toll-like receptor expression: The link between “danger” ligands and inflammation. Inflamm Allergy Drug Targets 2010; 9(5)322–333
   PubMedGoogle Scholar
• Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006; 107(2)637–641
   PubMed Web of Science ®Google Scholar
• Beaulieu LM, Freedman JE. The role of inflammation in regulating platelet production and function: Toll-like receptors in platelets and megakaryocytes. Thromb Res 2010; 125(3)205–209
   PubMed Web of Science ®Google Scholar
• Roy AL, Sen R, Roeder RG. Enhancer-promoter communication and transcriptional regulation of Igh. Trends Immunol 2011; 32(11)532–539
   PubMed Web of Science ®Google Scholar
• Netea MG, Van der Graaf C, Van der Meer JW, Kullberg BJ. Recognition of fungal pathogens by Toll-like receptors. Eur J Clin Microbiol Infect Dis 2004; 23(9)672–676
   PubMedGoogle Scholar
• Rødland EK, Ager-Wick E, Halvorsen B, Møller F, Frøland SS. Toll-like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro. Med Mycol 2011; 49(4)375–379
   PubMed Web of Science ®Google Scholar
• Davis RB, Meeker WR, McQuarrie DG. Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets. Circ Res 1960; 8: 234–239
   PubMedGoogle Scholar
• Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70(12)6524–6533
   PubMed Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002; 22(9)913–922
   PubMed Web of Science ®Google Scholar
• Liu CZ, Huang HY, Tsai PJ, Shih MH. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation andaggregation by Staphylococcus aureus bacteria. Thromb Res 2005; 116(2)145–155
   PubMedGoogle Scholar
• Sjøbring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002; 100(13)4470–4477
   PubMedGoogle Scholar
• Chia JS, Lin YL, Lien HT, Chen JY. Platelet aggregation induced by serotype polysaccharides from Streptococcus mutans. Infect Immun. 2004; 72(5)2605–2617
   PubMedGoogle Scholar
• Kalvegren H, Majeed M, Bengtsson T. Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: A causal role incardiovascular disease?. Arterioscler Thromb Vasc Biol 2003; 23(9)1677–1683
   PubMedGoogle Scholar
• Kalvegren H, Andersson J, Grenegård M, Bengtsson T. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. Eur J Pharmacol 2007; 566(1–3)20–27
   PubMedGoogle Scholar
• Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I. Agonists of Toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 2005; 94(4)831–838
   PubMed Web of Science ®Google Scholar
• Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009; 182(12)7997–8004
   PubMed Web of Science ®Google Scholar
• Schneberger D, Aharonson-Raz K, Singh B. Monocyte and macrophage heterogeneity and Toll-like receptors in the lung. Cell Tissue Res 2011; 343(1)97–106
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Mühlradt PF, Akira S. Cutting edge: Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J Immunol 2000; 164(2)554–557
   PubMed Web of Science ®Google Scholar
• Ghosh TK, Mickelson DJ, Solberg JC, Lipson KE, Inglefield JR, Alkan SS. TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha. Int Immunopharmacol 2007; 7(8)1111–1121
   PubMedGoogle Scholar
• Hirotani T, Lee PY, Kuwata H, Yamamoto M, Matsumoto M, Kawase I, Akira S, Takeda K. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 2005; 174(6)3650–3657
   PubMedGoogle Scholar
• Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20: 709–760
   PubMed Web of Science ®Google Scholar
• Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 2005; 115(1)66–75
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, Sharfstein SE, Graeber TG, Sieling PA, Liu YJ, Rea TH, et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 2005; 11(6)653–660
   PubMedGoogle Scholar
• Remer KA, Reimer T, Brcic M, Jungi TW. Evidence for involvement of peptidoglycan in the triggering of an oxidative burst by Listeria monocytogenes in phagocytes. Clin Exp Immunol 2005; 140(1)73–80
   PubMedGoogle Scholar
• Akira S, Takeda K, Kaisho T. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2(8)675–680
   PubMed Web of Science ®Google Scholar
• van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009; 85(2)195–204
   PubMed Web of Science ®Google Scholar
• Foss B, Ulvestad E, Hervig T, Bruserud O. Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia. Int J Cancer 2002; 97(1)106–114
   PubMedGoogle Scholar
• Li N, Hu H, Lindqvist M, Wikstrøm-Jonsson E, Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000; 20(12)2702–2708
   PubMed Web of Science ®Google Scholar
• Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991; 78(7)1760–1769
   PubMedGoogle Scholar
• da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006; 79(3)499–507
   PubMed Web of Science ®Google Scholar
• Yago T, Tsukuda M, Minami M. P-selectin binding promotes the adhesion of monocytes to VCAM-1 under flow conditions. J Immunol 1999; 163(1)367–373
   PubMedGoogle Scholar
• Bouchon A, Dietrich J, Colonna M. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164(10)4991–4995
   PubMed Web of Science ®Google Scholar
• Li G, Sanders JM, Bevard MH, Sun Z, Chumley JW, Galkina EV, Ley K, Sarembock IJ. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 2008; 172(4)1141–1152
   PubMed Web of Science ®Google Scholar
• Mourao-Sa D, Robinson MJ, Zelenay S, Sancho D, Chakravarty P, Larsen R, Plantinga M, Van Rooijen N, Soares MP, Lambrecht B, et al. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol 2011; 41(10)3040–3053
   PubMedGoogle Scholar
• Morrell CN, Maggirwar SB. Recently recognized platelet agonists. Curr Opin Hematol. 2011; 18(5)309–314
   PubMedGoogle Scholar
• Suzuki-Inoue K, Inoue O, Ozaki Y. Novel platelet activation receptor CLEC-2: From discovery to prospects. J Thromb Haemost 2011; 9(Suppl 1)44–55
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Ozaki Y. The novel platelet activation receptor CLEC-2. Platelets 2011; 22(5)380–384
   PubMed Web of Science ®Google Scholar
• Fuller GL, Williams JA, Tomlinson MG, Eble JA, Hanna SL, Pöhlmann S, Suzuki-Inoue K, Ozaki Y, Watson SP, Pearce AC. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade. J Biol Chem 2007; 282(17)12397–12409
   PubMed Web of Science ®Google Scholar
• Drummond RA, Brown GD. The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol 2011; 14(4)392–399
   PubMed Web of Science ®Google Scholar
• Drummond RA, Saijo S, Iwakura Y, Brown GD. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity. Eur J Immunol 2011; 41(2)276–281
   PubMedGoogle Scholar
• Saijo S, Iwakura Y. Dectin-1 and Dectin-2 in innate immunity against fungi. Int Immunol 2011; 23(8)467–472
   PubMed Web of Science ®Google Scholar
• Pollreisz A, Assinger A, Hacker S, Hoetzenecker K, Schmid W, Lang G, Wolfsberger M, Steinlechner B, Bielek E, Lalla E, et al. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro. Br J Dermatol 2008; 159(3)578–584
   PubMedGoogle Scholar
• Ankersmit HJ, Roth GA, Moser B, Zuckermann A, Brunner M, Rosin C, Buchta C, Bielek E, Schmid W, Jensen-Jarolim E, et al. CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: Implication of therapy-induced in vivo thrombocytopenia. Am J Transplant 2003; 3(6)754–759
   PubMed Web of Science ®Google Scholar
• Martini F, Riondino S, Pignatelli P, Gazzaniga PP, Ferroni P, Lenti L. Involvement of GD3 in platelet activation. A novel association with Fcgamma receptor. .Biochim Biophys Acta 2002; 1583(3)297–304
   PubMedGoogle Scholar
• Tapp LD, Shantsila E, Wrigley BJ, Pamukcu B, Lip GY, The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost 2011. doi: 10.1111/j.1538-7836.2011.04603.x. [Epub ahead of print] PubMed PMID: 22212813
   Google Scholar
• Torsteinsdóttir I, Arvidson NG, Hällgren R, Håkansson L. Monocyte activation in rheumatoid arthritis (RA): Increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999; 115(3)554–560
   PubMedGoogle Scholar
• El Kebir D, Zhang Y, Potempa LA, Wu Y, Fournier A, Filep JG. C-reactive protein-derived peptide 201-206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32. J Leukoc Biol 2011; 90(6)1167–1175
   PubMedGoogle Scholar
• Khreiss T, József L, Potempa LA, Filep JG. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 2004; 110(17)2713–2720
   PubMedGoogle Scholar
• Sioud M. Innate sensing of self and non-self RNAs by Toll-like receptors. Trends Mol Med 2006; 12(4)167–176
   PubMed Web of Science ®Google Scholar
• Pinto A, Morello S, Sorrentino R. Lung cancer and Toll-like receptors. Cancer Immunol Immunother 2011; 60(9)1211–1220
   PubMedGoogle Scholar
• Bruserud O, Wendelbo O, Paulsen K. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts. Eur J Haematol 2004; 73(5)340–350
   PubMedGoogle Scholar
• Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review. Chest 2011; 139(2)271–278
   PubMed Web of Science ®Google Scholar
• Levi M, Schultz M. Coagulopathy and platelet disorders in critically ill patients. Minerva Anestesiol 2010; 76(10)851–859
   PubMedGoogle Scholar
• Kitchens CS. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematol Am Soc Hematol Educ Program 2009; 1: 240–246
   Google Scholar
• Hu JY, Li CL, Wang YW, Altered proteomic pattern in platelets of rats with sepsis. Blood Cells Mol Dis. 2012;15;48(1):30–35
   Google Scholar
• Agrawal S, Hope W, Sinkó J, Kibbler C. Optimizing management of invasive mould diseases. J Antimicrob Chemother 2011; 66(Suppl 1)i45–i53
   PubMedGoogle Scholar
• Freemantle N, Tharmanathan P, Herbrecht R. Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease. J Antimicrob Chemother 2011; 66(Suppl 1)i25–i35
   Google Scholar
• Almyroudis NG, Segal BH. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther 2010; 8(12)1451–1466
   PubMed Web of Science ®Google Scholar
• Chen SC, Kontoyiannis DP. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis 2010; 23(6)567–577
   PubMed Web of Science ®Google Scholar
• Reikvam H, Mosevoll KA, Melve GK, Günther EC, Sjo M, Bentsen PT, Bruserud O, The pretransplant serum cytokine profile in allogeneic stem cell recipients differ from healthy individuals and different profiles are associated with different risk of posttransplant complications. Biol Blood Marrow Transplant. 2012;18(2):190–199
   Google Scholar
• Bruserud O, Foss B, Petersen H. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: Studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L). Eur Cytokine Netw 2001; 12(2)231–238
   PubMed Web of Science ®Google Scholar
• Bruserud O, Huang TS, Glenjen N, Gjertsen BT, Foss B. Leptin in human acute myelogenous leukemia: Studies of in vivo levels and in vitro effects on native functional leukemia blasts. Haematologica 2002; 87(6)584–595
   PubMed Web of Science ®Google Scholar
• Glenjen N, Mosevoll KA, Bruserud O. Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia. Int J Cancer 2002; 101(1)86–94
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11(4)275–288
   PubMed Web of Science ®Google Scholar
• Wendelbo O, Nesthus I, Sjo M, Paulsen K, Ernst P, Bruserud O. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia. Cancer Immunol Immunother 2004; 53(8)740–747
   PubMed Web of Science ®Google Scholar
• Wendelbo O, Nesthus I, Sjo M, Ernst P, Bruserud O. Cellular immune responses in multiple myeloma patients with treatment-induced cytopenia early after high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Leuk Res 2004; 28(5)461–468
   PubMedGoogle Scholar
• Wendelbo O, Bruserud O. Functional evaluation of proliferative T cell responses in patients with severe T lymphopenia: Characterization of optimal culture conditions and standardized activation signals for a simple whole blood assay. J Hematother Stem Cell Res. 2003; 12(5)525–535
   PubMedGoogle Scholar
• Engelhardt BG, Crowe JE, Jr. Homing in on acute graft vs. host disease: Tissue-specific T regulatory and Th17 cells. Curr Top Microbiol Immunol 2010; 341: 121–146
   PubMedGoogle Scholar
• Maghazachi AA. Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 2010; 341: 37–58
   PubMed Web of Science ®Google Scholar
• Melve GK, Ersvssr E, Kittang AO, Bruserud O. The chemokine system in allogeneic stem-cell transplantation: A possible therapeutic target?. Expert Rev Hematol 2011; 4(5)563–576
   PubMed Web of Science ®Google Scholar
• Apelseth TO, Hervig T, Bruserud O. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Blood Rev 2011; 25(3)113–122
   PubMedGoogle Scholar
• Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjørsvik S, Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007; 47(4)653–65
   PubMedGoogle Scholar
• Akkök CA, Hervig T, Stamnesfet S, Nesthus I, Melve GK, Lassalle P, Bruserud O. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy 2011; 13(10)1259–1268
   PubMed Web of Science ®Google Scholar
• Baltch AL, Bopp LH, Smith RP, Ritz WJ, Michelsen PB. Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes. J Antimicrob Chemother 2008; 62(6)1285–1290
   PubMed Web of Science ®Google Scholar
• Fidan I, Yuksel S, Imir T, Kalkanci A, Kustimur S, Ilhan MN. The effects of fluconazole and cytokines on human mononuclear cells. Mem Inst Oswaldo Cruz 2007; 102(2)127–131
   PubMedGoogle Scholar
• Simitsopoulou M, Roilides E, Paliogianni F, Likartsis C, Ioannidis J, Kanellou K, Walsh TJ. Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: Differential role of Toll-like receptors. Antimicrob Agents Chemother 2008; 52(9)3301–3306
   PubMed Web of Science ®Google Scholar
• Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, von Eiff C, Lass-Flørl C. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis 2008; 198(8)1243–1246
   PubMed Web of Science ®Google Scholar
• Perkhofer S, Trappl K, Striessnig B, Nussbaumer W, Lass-Flørl C. Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. Med Mycol 2011; 49(2)157–166
   PubMed Web of Science ®Google Scholar
• Leon CG, Tory R, Jia J, Sivak O, Wasan KM. Discovery and development of toll-like receptor 4 (TLR4) antagonists: A new paradigm for treating sepsis and other diseases. Pharm Res 2008; 25(8)1751–1761
   PubMedGoogle Scholar